cspc pharma limited submitted its latest monthly securities change report on September 30, 2024, showing that the company conducted share repurchases and cancellations in September 2024, resulting in a decrease in the number of issued shares. According to the report, cspc pharma had 11,859,741,732 shares issued at the end of last month, which decreased to 11,745,471,732 shares at the end of this month, a decrease of 114,270,000 shares. In addition, the company's share options plan became effective on December 9, 2015, and as of the end of the reporting period, the remaining number of share options is 30,500,000 shares, while the total number of shares that may be issued or transferred from treasury stock under the options granted as part of the plan is 541,101,840 shares. The report was submitted by the company secretary, Luo Tai'an, on October 2, 2024.

cspc pharma limited submitted its latest monthly securities change report on September 30, 2024, showing that the company conducted share repurchases and cancellations in September 2024, resulting in a decrease in the number of issued shares. According to the report, cspc pharma had 11,859,741,732 shares issued at the end of last month, which decreased to 11,745,471,732 shares at the end of this month, a decrease of 114,270,000 shares. In addition, the company's share options plan became effective on December 9, 2015, and as of the end of the reporting period, the remaining number of share options is 30,500,000 shares, while the total number of shares that may be issued or transferred from treasury stock under the options granted as part of the plan is 541,101,840 shares. The report was submitted by the company secretary, Luo Tai'an, on October 2, 2024.